Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C14H18N2 |
Molar mass | 214.312 g·mol−1 |
3D model ( JSmol) | |
|
Ciclindole ( INN; WIN-27,147-2), also known as cyclindole ( USAN), is an antipsychotic with a tricyclic structure that was never marketed. [1] [2] It displaces spiperone binding in vitro and elevates dopamine levels in the striatum, indicating it acts as a D2 receptor antagonist. [2]
Classes | |
---|---|
Antidepressants ( Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |
|
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C14H18N2 |
Molar mass | 214.312 g·mol−1 |
3D model ( JSmol) | |
|
Ciclindole ( INN; WIN-27,147-2), also known as cyclindole ( USAN), is an antipsychotic with a tricyclic structure that was never marketed. [1] [2] It displaces spiperone binding in vitro and elevates dopamine levels in the striatum, indicating it acts as a D2 receptor antagonist. [2]
Typical |
|
---|---|
Disputed | |
Atypical | |
Others |
|
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
Classes | |
---|---|
Antidepressants ( Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |
|